The Company granted 1.9 and 0.9 of restricted stock units and performance stock units, respectively, during the three months ended March 31, 2026 with weighted average grant date fair values of $9.57 and $11.66 per share.

Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated statements of operations were as follows:


	Three Months Ended March 31,
	2026		2025
Direct costs	$	8.1	$	11.6
Selling, general and administrative expenses	3.3		3.0
Total stock compensation expense	$	11.4	$	14.6

Income tax benefits	$	1.9	$	2.3